Navigation Links
Scripps Research Institute announces five-year research collaboration with Bristol-Myers Squibb
Date:6/15/2012

LA JOLLA, CA June 15, 2012 The Scripps Research Institute today announced it has entered into a five-year collaboration with Bristol-Myers Squibb Company (NYSE:BMY) focused on applying novel chemistry to drug discovery and synthesis.

The collaboration will revolve around support for projects of mutual interest to Bristol-Myers Squibb and a number of Scripps Research chemistry laboratories. Scripps Research investigators and senior scientists from Bristol-Myers Squibb collaborated to develop research plans incorporated into the new agreement.

"This agreement is an exciting development for The Scripps Research Institute," said Scripps Research President and CEO Michael A. Marletta. "It serves as a great example of how we will engage corporate partners in both understanding and treating disease. I look with anticipation to the outcome of this multi-lab collaboration."

In broad terms, the research will utilize Scripps Research investigators' expertise in applying chemistry methodologies to prepare novel synthetic intermediates and analogs for biological evaluation against Bristol-Myers Squibb targets.

"This arrangement is exemplary of our forward-looking corporate partnership strategy, as the first of what we hope will be many such agreements existing in parallel, " said Scott Forrest, vice president for business development at Scripps Research.


'/>"/>

Contact: Mika Ono
mikaono@scripps.edu
Scripps Research Institute
Source:Eurekalert

Page: 1

Related biology news :

1. Scripps Research discoveries lead to newly approved drug for infant respiratory distress syndrome
2. Scripps Research Institute scientists find promising vaccine targets on hepatitis C virus
3. Scripps Research Institute Professor Gerald F. Joyce elected to American Academy of Arts & Sciences
4. Scripps Research Institute scientists develop antidote for cocaine overdose
5. Scientist wins $3 million renewal of one of longest-running NIH grants to Scripps Research
6. Scripps research scientists find anticonvulsant drug helps marijuana smokers kick the habit
7. Scripps Florida scientist awarded $1.5 million to design therapeutics with new RNA approach
8. Scripps Florida scientists identify neurotranmitters that lead to forgetting
9. Plastic trash altering ocean habitats, Scripps study shows
10. Scripps Florida scientists awarded $8.4 million grant to develop new anti-smoking treatments
11. Esther B. OKeeffe Foundation gives $2 million to the Scripps Research Institute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... -- The potential for clinical use of induced ... strategies has previously been hindered by the risk ... tumors. The ability to use etoposide treatment to ... of heart disease, specifically acute myocardial infarction, is ... and Development , a peer-reviewed journal from Mary ...
(Date:7/23/2014)... mollusks, starfish, and corals have in common? Aside ... calcifiersorganisms that use calcium from their environment to ... and protection. , The July issue of ... Biological Laboratory, addresses the challenges faced by these ... atmospheric carbon dioxide rises, the world,s oceans are ...
(Date:7/23/2014)... -- BCC Research ( www.bccresearch.com ... AND TECHNOLOGIES FOR SENSORS , the global market for ... nearly $154.4 billion by 2020, with a five-year compound ... and level sensors segment is moving at a significant ... , Sensors have become indispensable to many ...
Breaking Biology News(10 mins):Calcification in changing oceans explored in special issue of The Biological Bulletin 2Global Market for Sensors to Reach Nearly $154.4 Billion in 2020; Image Sensors Moving at 11.7% 2Global Market for Sensors to Reach Nearly $154.4 Billion in 2020; Image Sensors Moving at 11.7% 3
... study of men and post-menopausal women primarily over 60 ... with greater bone mineral density (BMD). Researchers at the ... (USDA HNRCA) at Tufts University found associations were strongest ... lower in men drinking more than two servings of ...
... -- Ben-Gurion University of the Negev (BGU) researchers have ... reversible panes that will save energy all year round ... Window, features the only glazing system that permits effective ... temperature near a window and reduces unwanted solar gains ...
... of the American Dietetic Association features research studies ... of the life cycle, from children and adolescents to ... Consumption among U.S. Children , Children and adolescents ... to researchers at Ohio State University. The researchers ...
Cached Biology News:Moderate alcohol intake associated with bone protection 2Moderate alcohol intake associated with bone protection 3Ben-Gurion University of the Negev researchers develop new reversible, green window technology 2News from the March 2009 Journal of the American Dietetic Association 2
(Date:7/23/2014)... Ill. , July 23, 2014 /PRNewswire/ ... (SNA™) constructs as gene regulatory and immunotherapeutic ... has joined AuraSense Therapeutics, executive leadership ... 11. Prior to joining AuraSense ... and Chief Financial Officer of Cellular Dynamics ...
(Date:7/23/2014)... 23 de julio de 2014 ADB ... Compañía) ha anunciado hoy una asociación con Austen ... (ABIA o el Instituto), para el propósito de ... de terapia de señal bioeléctrica (el E-QURE BST ... Instituto, que tiene una importante experiencia en cicatrización ...
(Date:7/23/2014)... 2014 /PRNewswire/ - BioAmber Inc. (NYSE: ... chemicals, today announced that the underwriters of its common ... purchase an additional 420,000 shares of common stock ... share, less underwriting discounts and commissions, in connection ... 2,800,000 shares of common stock, bringing the expected ...
(Date:7/23/2014)... PARK, Calif. , July 23, 2014  Sofinnova ... investment firm, today announced the closing of Sofinnova Venture ... million and in excess of the initial fund target ... helping entrepreneurs build successful biotechnology companies. Consistent with recent ... with promising later stage clinical programs, along with select ...
Breaking Biology Technology:AuraSense Therapeutics Appoints Biotechnology Veteran David S. Snyder as Chief Financial Officer 2ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 2ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 3ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 4ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 5ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 6BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering 2BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering 3Sofinnova Raises $500 Million Biotech Venture Fund 2
... $68.6 Million, Increase of 32% Over Second Quarter 2007, - EPS of ... - Earnings Before Non-Cash Charges of $1.36 per Basic Share, Increase of ... 56% Over Second ... UTHR ) today announced its results of,operations for the quarter ended ...
... California, Berkeley, have devised a way to squeeze light ... doors to new technology in the fields of optical ... succeeded previously in passing light through gaps 200 nanometers ... a human hair. A group of UC Berkeley researchers ...
... Inc.,(Nasdaq: ITMN ) today announced that Daniel G. ... the BMO Capital Markets 2008 Focus,on Healthcare Conference in ... EDT., To access a live audio webcast of ... to the investor relations page of InterMune,s,corporate website at ...
Cached Biology Technology:United Therapeutics Reports Second Quarter 2008 Financial Results 2United Therapeutics Reports Second Quarter 2008 Financial Results 3United Therapeutics Reports Second Quarter 2008 Financial Results 4United Therapeutics Reports Second Quarter 2008 Financial Results 5United Therapeutics Reports Second Quarter 2008 Financial Results 6New technique to compress light could open doors for optical communications 2New technique to compress light could open doors for optical communications 3
Lentigen's manufacturing platform is sufficiently versatile for use in the manufacture of any HIV-based Lentiviral vector. Lentigen will manufacture your LV of choice to the highest possible titer a...
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Biology Products: